![When should we order a next generation sequencing test in a patient with cancer? - eClinicalMedicine When should we order a next generation sequencing test in a patient with cancer? - eClinicalMedicine](https://www.thelancet.com/cms/asset/8f79473d-e135-42c7-8e48-de1763def587/gr1.jpg)
When should we order a next generation sequencing test in a patient with cancer? - eClinicalMedicine
![Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience](https://www.frontiersin.org/files/MyHome%20Article%20Library/687730/687730_Thumb_400.jpg)
Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience
![Study schema. FM Foundation Medicine, NGS next-generation sequencing,... | Download Scientific Diagram Study schema. FM Foundation Medicine, NGS next-generation sequencing,... | Download Scientific Diagram](https://www.researchgate.net/publication/351092959/figure/fig1/AS:1023469630287874@1621025583498/Study-schema-FM-Foundation-Medicine-NGS-next-generation-sequencing-NTRK-neurotrophic.png)
Study schema. FM Foundation Medicine, NGS next-generation sequencing,... | Download Scientific Diagram
![Ligating colocalized targets and foundations to pre-existing adapters... | Download Scientific Diagram Ligating colocalized targets and foundations to pre-existing adapters... | Download Scientific Diagram](https://www.researchgate.net/publication/365275362/figure/fig1/AS:11431281098334000@1668850407477/Ligating-colocalized-targets-and-foundations-to-pre-existing-adapters-on-the-NGS-chip.png)
Ligating colocalized targets and foundations to pre-existing adapters... | Download Scientific Diagram
![Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience](https://www.frontiersin.org/files/Articles/687730/fonc-11-687730-HTML/image_m/fonc-11-687730-t001.jpg)
Frontiers | The Impact of Foundation Medicine Testing on Cancer Patients: A Single Academic Centre Experience
![U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for AstraZeneca's Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) to Identify Patients with HR-Positive, HER2-Negative Advanced Breast Cancer | Business Wire U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for AstraZeneca's Truqap™ (capivasertib) in combination with Faslodex® (fulvestrant) to Identify Patients with HR-Positive, HER2-Negative Advanced Breast Cancer | Business Wire](https://mms.businesswire.com/media/20231120975726/en/794671/22/FMI_horizontal.jpg)